Results 271 to 280 of about 537,193 (355)

Systems-level exploitation of OxyR regulon unravels a potential antibacterial target in Pseudomonas aeruginosa. [PDF]

Commun Biol
Cui K, Fu Z, Sun R, You Q, Wang F, Sun X, Tan Y, Xia Y, Wang P, Wei Q, Wang D, Yang W.   +11 more
europepmc   +1 more source

Cyanide Production by Pseudomonas Aeruginosa

, 1967
Walter Goldfarb, Harry W. Margraf
openalex   +2 more sources

Selenium biofortification: integrating one health and sustainability

Journal of the Science of Food and Agriculture, EarlyView.
Abstract Selenium (Se) biofortification in crops has emerged as a promising strategy to address global Se deficiencies and enhance both agricultural productivity and human health. Increasing the Se content of crops through biofortification improves their resilience to abiotic and biotic stresses and boosts their nutritional value.
Silvia Estarriaga‐Navarro, Nieves Goicoechea, Daniel Plano, Carmen Sanmartín   +3 more
wiley   +1 more source

Cutaneous Granulomas Associated With Rubella Replication in TAP Deficiency Syndrome: A Fatal Case Report Evolving Into Cutaneous Squamous Cell Carcinoma and EBV‐Associated Lymphoproliferative Syndrome

JEADV Clinical Practice, EarlyView.
ABSTRACT Transporter associated with antigen presentation (TAP) deficiency syndrome (TDS) is a rare primary immunodeficiency (PID) characterised by a broad spectrum of clinical manifestations, with noninfectious cutaneous granulomas (CG) being a common feature.
A. Fernández‐Galván, M. Aparicio, P. Muñoz, J. Fulgencio‐Barbarín, N. D. Zurita, D. Arroyo‐Sánchez, O. Cabrera‐Marante, L. M. Allende, M. Llamas‐Velasco   +8 more
wiley   +1 more source

Colistin resistance dynamics in <i>Pseudomonas aeruginosa</i> under biofilm and planktonic growth. [PDF]

Antimicrob Agents Chemother
Alarcon Rios AC, Zwep LB, Vriesendorp B, Knibbe CAJ, Ciofu O, Liakopoulos A, Aulin LBS, Rozen DE, van Hasselt JGC.   +8 more
europepmc   +1 more source

Isolation and characterization of a novel bacteriophage PUTH1 active against Pseudomonas aeruginosa. [PDF]

Virol J
Tan Q, Ye J, Zhu T, Tian Y.
europepmc   +1 more source

[Kinetic studies of the reaction mechanism of carnitine dehydrogenase of Pseudomonas aeruginosa].

, 1969
W Schöpp, H. Sorger, H.‐P. Kleber, H. Aurich   +3 more
openalex  

Atypical Wounds in Chronic Graft‐Versus‐Host Disease and Peripheral Arterial Disease Caused by Tyrosine Kinase Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer, K. Malik, C. Willers, M. Augustin   +3 more
wiley   +1 more source

Correction: Systematic bacteriophage selection for the lysis of multiple <i>Pseudomonas aeruginosa</i> strains. [PDF]

Front Cell Infect Microbiol
Rieper F, Wittmann J, Bunk B, Spröer C, Häfner M, Willy C, Müsken M, Ziehr H, Korf IHE, Jahn D.   +9 more
europepmc   +1 more source